| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, among the Company, as issuer, and BNP Paribas Securities Corp., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Mizuho Securities USA LLC and the several other underwriters named in Schedule A thereto",
"Twenty-Seventh Supplemental Indenture, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP" |
|
| 08/08/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 08/07/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/04/2023 |
10-Q
| Quarterly Report for the period ended July 1, 2023 |
| 08/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended April 1, 2023 |
| 05/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/26/2023 |
8-K
| Quarterly results |
| 03/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/23/2023 |
IRANNOTICE
| Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).: |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.3% stake in Thermo Fisher Scientific Inc. |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
8-K
| Quarterly results |
| 11/22/2022 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 11/21/2022 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 11/21/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, among the Company, as issuer, and Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and Merrill Lynch International and the several other underwriters named in Schedule A thereto",
"Underwriting Agreement, among the Company, as issuer, and BofA Securities, Inc., Citigroup Global Markets Inc. and Deutsche Bank Securities Inc., as representatives of the several underwriters named in Schedule A thereto",
"Twenty-Fifth Supplemental Indenture, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee",
"Twenty-Sixth Supplemental Indenture, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP" |
|
|